NCT07147309View on ClinicalTrials.gov

Multimodal PET Imaging With 18F-FDG/SV2A/TSPO for Resection Planning in Drug-Resistant Epilepsy

Not yet recruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

September 1, 2029

Study Completion Date

September 1, 2029

Conditions
EpilepsyPET / MRSynaptic Vesicle ProteinsMicroglial ActivationFDG PET
All Listed Sponsors
lead

Weibing Miao, PhD

OTHER

NCT07147309 - Multimodal PET Imaging With 18F-FDG/SV2A/TSPO for Resection Planning in Drug-Resistant Epilepsy | Biotech Hunter | Biotech Hunter